Log In
BCIQ
Print this Print this
 

Serotonin (5-HT2C) receptor

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Serotonin (5-HT2C) receptor

BCIQ
Print ChartPrint this
1 0 0 0 0 0 1 0 0 1 0 0 0 1 1 1 0 1 0 0 1 0 1 0
Phases of DevelopmentDiscoveryPreclinicalPhase IPhase IIPhase IIIMarketed
Autoimmune

0

0

1

0

1

0

Endocrine / Metabolic

0

1

1

1

0

1

Neurology

1

0

0

1

0

0

Ophthalmic

1

0

0

0

0

0




 Products Targeting Serotonin (5-HT2C) receptor
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

7

$1,727.3M

$57.0M

$1,323.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today